Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
Weatherald J, Thakrar MV, Varughese RA, Kularatne M, Liu J, Harper L, Kiamanesh O, Fine N, Orlikow E, Nwaroh C, Thornton C, Swiston J, Kolkman L, Brunner NW, Helmersen D, Hirani N. Weatherald J, et al. Among authors: varughese ra. J Heart Lung Transplant. 2022 May;41(5):563-567. doi: 10.1016/j.healun.2022.01.002. Epub 2022 Jan 10. J Heart Lung Transplant. 2022. PMID: 35090807 Clinical Trial.